netFormulary NHS
NHS Bath and North East Somerset, Swindon and Wiltshire CCG
Royal United Hospitals Bath NHS Foundation Trust
Great Western Hospitals NHS Foundation Trust
Salisbury NHS Foundation Trust
 Search
 Formulary Chapter 4: Central nervous system - Full Section
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
04.01 Hypnotics and anxiolytics (0,1)
04.01.01 Hypnotics (1,1)
spacespace Benzodiazepines (1,3)
spacespace Zaleplon, Zolpidem and Zopiclone (1,2)
spacespace Chloral and derivatives (1,2)
spacespace Clomethiazole (Chlormethiazole) (0,1)
spacespace Antihistamines (1,0)
spacespace Alcohol (0,0)
spacespace Sodium oxybate (0,1)
04.01.02 Anxiolytics (5,0)
spacespace Benzodiazepines (4,2)
spacespace Buspirone (1,0)
spacespace Beta blockers (1,0)
spacespace Meprobamate (0,1)
04.01.03 Barbiturates (0,4)
04.02 Drugs used in psychoses and related disorders (0,0)
04.02.01 Antipsychotic Drugs (8,10)
spacespace First-Generation Antipsychotic Drugs (0,0)
spacespace Second-Generation Antipsychotic Drugs (7,4)
04.02.02 Antipsychotic depot injections (7,2)
04.02.03 Drugs used for mania and hypomania (1,1)
spacespace Benzodiazepines (0,0)
spacespace Antipsychotic drugs (0,0)
spacespace Carbamazepine (1,0)
spacespace Valproic acid (2,0)
spacespace Lithium (4,0)
04.03 Antidepressant drugs (0,0)
04.03.01 Tricyclic and related antidepressant drugs (0,0)
spacespace Tricyclic antidepressants (4,9)
spacespace Related antidepressants (1,1)
04.03.02 Monoamine-oxidase inhibitors (1,2)
spacespace Reverible MAOIs (1,0)
04.03.03 Selective serotonin re-uptake inhibitors (6,2)
04.03.04 Other antidepressant drugs (3,5)
04.04 CNS stimulants and other drugs used for attention deficit hyperactivity disorder (4,1)
spacespace Cocaine (0,0)
04.05 Drugs used in the treatment of obesity (0,0)
04.05.01 Anti-obesity drugs acting on the gastro-intestinal tract (1,2)
04.05.02 Centrally acting appetite suppressants (0,2)
04.06 Drugs used in nausea and vertigo (0,1)
spacespace Vomiting during pregnancy (0,0)
spacespace Postoperative nausea and vomiting (0,0)
spacespace Motion sickness (0,0)
spacespace Other vestibular disorders (0,0)
spacespace Cytotoxic chemotherapy (0,0)
spacespace Palliative care (0,0)
spacespace Migraine (0,0)
spacespace Antihistamines (3,1)
spacespace Phenothiazines and related drugs (2,1)
spacespace Domperidone and metoclopramide (2,0)
spacespace 5HT3 antagonists (1,5)
spacespace Neurokinin receptor antagonist (1,1)
spacespace Cannabinoid (0,1)
spacespace Hyoscine (2,0)
spacespace Other drugs for Ménière's disease (1,0)
04.07 Analgesics (1,0)
04.07.01 Non-opioid analgesics and compound analgesic preparations (0,0)
spacespace Compound analgesic preparations (6,9)
04.07.02 Opioid analgesics (15,23)
04.07.03 Neuropathic pain (7,1)
spacespace Trigeminal neuralgia (1,1)
spacespace Postherpetic neuralgia (1,0)
spacespace Chronic facial pain (0,0)
04.07.04 Antimigraine drugs (0,0)
04.07.04.01 Treatment of the acute migraine attack (0,0)
spacespace Analgesics (0,4)
spacespace 5HT1 agonists (4,4)
spacespace Ergot alkaloids (0,2)
spacespace Anti-emetics (0,0)
spacespace Other drugs for migrane (0,1)
04.07.04.02 Prophylaxis of migraine (9,3)
04.07.04.03 Cluster headache (0,0)
04.08 Antiepileptics (0,0)
04.08.01 Control of epilepsy (1,1)
spacespace Partial seizures with or without secondary generalisation (0,0)
spacespace Generalised seizures (0,0)
spacespace Carbamazepine and Oxcarbazepine (3,0)
spacespace Ethosuximide (1,0)
spacespace Gabapentin and pregabalin (2,0)
spacespace Lacosamide (1,0)
spacespace Lamotrigine (1,0)
spacespace Levetiracetam (2,0)
spacespace Perampanel (0,0)
spacespace Phenobarbital and other barbiturates (2,0)
spacespace Phenytoin (1,0)
spacespace Retigaine (0,0)
spacespace Rufinamide (1,0)
spacespace Rufinamide (0,0)
spacespace Tiagabine (0,1)
spacespace Topiramate (1,0)
spacespace Valproate (2,1)
spacespace Vigabatrin (1,0)
spacespace Zonisamide (1,0)
spacespace Benzodiazepines (2,0)
spacespace Other Drugs (1,2)
04.08.02 Drugs used in status epilepticus (8,4)
04.08.03 Febrile convulsions (0,0)
04.09 Drugs used in parkinsonism and related disorders (0,0)
04.09.01 Dopaminergic drugs used in Parkinsons disease (0,1)
spacespace Dopamine receptor agonists (4,5)
spacespace Levodopa (3,1)
spacespace Monoamine-oxidase-B inhibitors (3,0)
spacespace Catachol-O-methyltransferase inhibitors (2,1)
spacespace Amantadine (1,0)
04.09.02 Antimuscarinic drugs used in parkinsonism (3,1)
04.09.03 Drugs used in essential tremor, chorea, tics, and related disorders (3,2)
spacespace Torsion dystonias and other involuntary movements (0,3)
04.10 Drugs used in substance dependence (0,0)
spacespace Alcohol dependence (0,0)
spacespace Cigarette smoking (0,0)
spacespace Opioid dependence (0,2)
04.10.01 Alcohol dependence (5,0)
04.10.02 Nicotine dependence (3,1)
04.10.03 Opioid dependence (0,0)
spacespace Opioid substitution therapy (3,1)
spacespace Adjunctive therapy and symptomatic treatment (1,1)
spacespace Opioid-receptor antagonists (1,0)
04.11 Drugs for dementia (4,0)
netFormulary